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T cell suppression is a well established phenomenon, but the mechanisms involved are still a matter of
debate. Mouse anergic T cells were shown to suppress responder T cell activation by inhibiting the
antigen presenting function of DC. In the present work we studied the effects of co-culturing human
anergic CD4
þ T cells with autologous dendritic cells (DC) at different stages of maturation. Either DC
maturation or survival, depending on whether immature or mature DC where used as APC, was
impaired in the presence of anergic cells. Indeed, MHC and costimulatory molecule up-regulation was
inhibited in immature DC, whereas apoptotic phenomena were favored in mature DC and consequently
in responder T cells. Defective ligation of CD40 by CD40L (CD154) was responsible for CD95-
mediated and spontaneous apoptosis of DC as well as for a failure of their maturation process. These
ﬁndings indicate that lack of activation of CD40 on DC by CD40L-defective anergic cells might be the
primary event involved in T cell suppression and support the role of CD40 signaling in regulating both
activation and survival of DC.
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INTRODUCTION
T cells can transfer tolerance from a tolerant to a naı ¨ve
host (Gerson, 1975; Charlton et al., 1994) a phenomenon
referred to as “infectious tolerance” (Zhai and Kupie-
Weglinski, 1999). We have shown that human CD4
þ T
cells, rendered tolerant, exert suppressive activity on
responder T cells in vitro (Lombardi et al., 1994; Frasca
et al., 1997). To assess whether suppression was mediated
through the APC as shown in mice (Vendetti et al., 2000),
here we analysed the susceptibility of both immature and
mature human DC to suppressive signals mediated by
CD4
þ T cell clones anergized with OKT3 mAb (Frasca
et al., 1997). Moreover, we followed the fate of responder
cells cultured with these DC in the presence of anergic
cells.
RESULTS
Anergic T Cells Exert Suppression in the Presence of
both Immature and Mature DC
We have demonstrated previously that human anergic
CD4
þ T cells suppress proliferation of responder T cells to
EBV-B transformed B cell lines (B-LCL) presenting
antigen to both cell types (Lombardi et al., 1994;
Frasca et al., 1997). Here we wanted to analyze the same
phenomenon in a more physiological condition using DC
as APC. Clone F17, HA307-19-speciﬁc and DRB1*1101-
restricted, was in part either anergized (Frasca et al., 1997)
or activated with PMA þ I. Figure 1 shows its suppressive
activity on responder cells of the same clone
(anergic/responder cells ratio 3:1), in the presence of
both immature and mature DRB1*1101
þ HA307-19-
pulsed DC. Data are expressed as percentage of
suppression of responder cells proliferation. It is clear
that anergic cells exert suppression independently on the
maturational stages of DC. As control, T cells activated
with PMA þ I did not affect responder cell proliferation.
To learn about the mechanism of suppression, we ﬁrst
evaluated expression of HLA-DR and CD86 molecules on
DC pulsed with HA307-19 and cultured with either
anergic or activated F17. In fact, we wanted to verify a
possible inhibitory effect of anergic cells on the
stimulatory capacity of DC. Figure 2a shows that culture
with activated cells (and also responder cells, not shown)
increased the percentage of these molecules expression on
immature (but not mature) DC after 48h of co-culture, as
measured by FACS. In contrast, culture with anergic cells
did not. Of note, no modiﬁcation of these molecules
expression was observed when mature DC were used in
the experiment. This result suggested that, in the presence
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by antagonizing maturating stimuli provided by responder
cells. To verify this, induction of CD86 up-regulation by
responder F17 was assessed in the presence or absence of
anergic cells (Fig. 2b). When anergic cells were present in
the culture together with responder cells CD86 up-
regulation in DC was strongly reduced showing that our
hypothesis was correct. However, we wonder how anergic
cells could exert suppression in the presence of fully
mature DC that did not modify their phenotype in any
condition (Fig. 2a). Since in our hands mature DC
expressed high amount of CD95, unlikely the immature
ones and anergic T cells expressed CD95L (data not
shown) we veriﬁed the possible implication of CD95-
mediated apoptosis in suppression. We ﬁrst assessed the
ability of anergic cells to inhibit proliferation of responder
cells after incubation of either responder T cells or DC,
separately, with the antagonistic anti-CD95 antibody M3.
When either DC or responder T cells were treated (Fig. 3a)
suppression was reduced. To conﬁrm these data we
performed a cytotoxic assay in which all three cells types
(responder cells, anergic cells, and mature DC) were
present in the same culture at the ratio utilized in
proliferation experiments. Anergic cells were the effectors
in the assay and we marked with
51Cr either only
responder T cells or DC in the same well. We also
assessed direct killing of target DC or responder cells
alone. The results in Fig. 3b show that DC and responder
cells were killed in a signiﬁcant fashion in the presence of
anergic cells when all three-cell types were present in the
same culture. Death was mainly mediated via CD95-
CD95L. In contrast, the capacity of anergic cells to kill
separately responder cells or mature DC was different.
Only DC were signiﬁcantly killed in this condition.
We interpret this as an indication that anergic cells kill not
only the APC, but also responder cells, only when the
three cell types come into contact by interactions driven
by antigen recognition.
FIGURE 1 Anergic T cells inhibit T cell proliferation induced by
“mature” and “immature” DC. Responder F17 (5 £ 10
3) was cultured
for 72h with 5 £ 10
3 DRB1*1101
þ “mature” or “immature” DC pulsed
with HA307-19 in the absence or in the presence of 1.5 £ 10
4 either
anergic (F17OKT3)or PI-activated F17 (F17PI).The resultsobtainedin a
proliferation assay, are expressed as percent of inhibition of responder
F17 proliferation and derived by one representative experiment.
FIGURE 2 Anergic T cells fail to upregulate MHC class II and CD86
molecule expression on “immature” DC cells and inhibit CD86
upregulation induced by responder cells. (a) 2 £ 10
4 “immature” or
“mature” DRB1*1101
þ DC, pulsed with HA307-19, were cultured either
alone (2) or with activated F17 (PI) or with F17 anergized on
immobilized OKT3 antibody (OKT3) at 378C for 48h. (b) 4 £ 10
4
“immature” DRB1*1101
þ DC pulsed with HA307-19 were cultured
either alone (2) or with activated F17 (PI) or both activated and anergic
F17 (PI þ OKT3) (anergic or activated/anergic T cell ratio 3:1) for 48h.
Data in (a) and (b), shown as percent of expression of each marker
measured by FACS, are from one of two separate experiments.
FIGURE 3 Anergic T cells kill both DC and responder T cells, mainly
through the CD95-CD95L system. (a) 5 £ 10
3 responder F17 cells were
cultured with the speciﬁc DC in the absence or in the presence of anergic
T cells at anergic/responder cells ratio 3:1. Responder cells and DC
cultured in the presence of anergic cells were untreated (2) or either
responder cells (M3 on F17R) or DC (M3 on DC) were pre-treated with
5mg/ml of antagonistic anti-CD95 antibody (M3). Results are expressed
as in Fig. 1. (b) Effector 9 £ 10
3 F17 anergic T cells were cultured with
3 £ 10
3 DRB1*1101
þ unlabeled DC þ 3 £ 10
35 1 Cr-labeled responder
F17 (
51Cr F17R þ DC) or with 3 £ 10
35 1 Cr-labeled DC þ 3 £ 10
3
unlabeled F17 (F17R þ
51Cr DC) or with 3 £ 10
3 responder F17 (
51Cr
F17R) or DC (
51Cr DC) alone. The results, expressed as percentage of
speciﬁc lysis, are representative of two experiments.
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1 T Cells Show Defective
Up-regulation of CD40L
To understand the reason for lack of maturation of
immature DC and increased apoptosis of mature DC in the
presence of anergic cells we measured CD40L expression
by anergic cells. We looked at CD40L because tolerant
T cells from mice were described to express altered level
of this molecule (Bowen et al., 1995). Moreover, it has
been shown that engagement of CD40 by CD40L prevents
both spontaneous and CD95-induced cell death of DC
(Ludewig et al., 1995; Bjorck et al., 1997; Koppi et al.,
1997) and activates immature DC, a phenomenon
described as APC “conditioning” or “licensing”
(Lanzavecchia, 1998). Figure 4 shows the kinetic of
CD40L expression on clone F17 following activation with
PMA þ I or with DRB1*1101
þ B-LCL pulsed with
HA307-19, and after anergy induction expressed as mean
ofﬂuorescenceintensity(MFI)measuredbyFACS.Tcells
receiving activating stimuli signiﬁcantly up-regulated
CD40L, whereas anergic cells did not. To produce
functional data, we activated CD40 molecules on target
DC by a cross-linked anti-CD40 mAb (M.M.) and used
again anergic F17 as effector in a cytotoxic assay. As an
important control, we tested the capacity of PI-activated
cells, unable to exert suppression in Fig. 1, to kill DC.
These cells also express CD95L (a typical activation
marker, not shown) together with high amount of CD40L,
unlikely anergic cells shown to be CD95L
þ in the absence
of CD40L up-regulation, and they should rescue DC from
apoptosis. Indeed, the results in Fig. 5a conﬁrm the
expectation that the killing capacity of high CD40L-
expressing activated T cells against target DC was lower
than that of anergic cells (although also mainly dependent
on CD95-pathway, not shown). Moreover, in the same
experiment we observed inhibition of apoptosis of DC
activated through CD40. This strongly supported the idea
that increased death of DC, in the presence of anergic
cells, was due to lack of CD40 engagement on these APC.
We reasoned that if this hypothesis was correct, we should
observe suppressive phenomena in the presence not only
of anergic but also activated cells when CD40–CD40L
interaction is interrupted during T-DC contact. To verify
this, we pre-treated both activated and anergic cells with
an antagonistic anti-CD40L mAb and repeated suppres-
sion experiments. As expected, in these conditions also
activated cells could exert suppression (Fig. 5b) conﬁrm-
ing that by disrupting CD40–CD40L interaction protec-
tion of DC from death during cognate interaction with
CD95L
þ T cells was abolished. To conﬁrm that poor
CD40L expression by anergic cells was insufﬁcient for a
productive interaction with CD40 on DC we decided to
look at Bcl-2 expression in DC cultured with either
activated or anergic cells. CD40 engagement produces up-
regulation of this anti-apoptotic molecule (Bjorck et al.,
1997; Koppi et al., 1997) mainly implicated in protection
FIGURE 4 Anergic CD4
þ T cells show impaired expression of CD40L.
2 £ 10
5 cells of F17 clone were either untreated (2) or anergized with
immobilized OKT3 (OKT3) or stimulated with 3 £ 10
5 HLA-
DRB1*1101
þ B-LCL pre-pulsed o.n. with 10mg/ml of HA307-19 (Ag)
or with PMA þ I (PI) in 48-well plates. Cells were cultured at 378C and
CD40L expression was assessed by staining with PE-conjugated anti-
human CD40L mAb (TRAP-1). The results are expressed as mean of
ﬂuorescence intensity (MFI) measured by FACS and derived from one of
four separate experiments.
FIGURE 5 CD40/CD40L interaction protects DC from death and
treatment of activated T cells with anti-CD40L antagonistic antibody
favors suppressive phenomena. (a) Either 9 £ 10
3 effector anergic




þ “mature” DC either
untreated or treated with a cross-linked anti-CD40 mAb (G28-5) as
indicated. The results are expressed as the percentage of speciﬁc
51Cr
release and are representative of two experiments. (b) Responder F17
(5 £ 10
3 cells) was cultured with 5 £ 10
3 DRB1*1101
þ “mature” DC
pulsed with HA307-19 either alone or in the presence of 1.5 £ 10
4 F17
anergic cells (F17OKT3) or in the presence of 1.5 £ 10
4 PMA þ I
stimulated F17 T cells (F17PI) either untreated or treated with the
antagonistic anti-CD40L antibody as indicated. Data are reported as in
Fig. 1.
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mediated apoptosis is still controversial). Following
intracellular staining of DC cultured for 24h with anergic
or activated F17 (and responder F17, not shown) we found
that (Fig. 6) anergic cells were unable to induce Bcl-2 up-
regulation as compared to non-anergic cells. Of note,
we observed a reduction of more than 50% of spontaneous
apoptosis of DC only in the presence of activated, but
not anergic cells (data not shown) after 24 and 48h
of co-culture.
DISCUSSION
The principal novelty of our work is that human anergic
T cells can always suppress the APC function of DC: (i) by
inhibiting their maturation process (ii) by triggering
apoptotic pathways in fully mature DC.
Our results reinforce the important role of CD40 as
regulatory molecule of DC function and demonstrate that
CD40 engagement on DC can be modulated by regulation
of its natural ligand expression on helper T cells. Although
DC can receive maturating stimuli from pathogens, it is
well known that helper T cells exert a predominant role in
the activation of these APC (a phenomenon described as
licensing or conditioning, Lanzavecchia, 1998). Therefore
the induction of CD40L-defective anergic cells can be a
mechanism that by impairing T cell help, eventually lead
to inhibition of immunity. Moreover, since the same
interaction also regulates CD95-mediated apoptotic path-
ways in DC (as well as spontaneous elimination of
DC, Bjorck et al., 1997; Koppi et al., 1997) it is plausible
that in vivo mature DC survive when encountering
properly activated speciﬁc CD40L
þ T cells, but die in
the presence of not properly activated CD40L-defective
T cells (namely anergic T cells). Of interest, DC acquire
susceptibility to the active pathway of apoptosis
(CD95/CD95L-mediated) after full maturation. Indeed,
in our hands, DC cultured for 6 days with GM-CSF
and IL-4 did not express detectable levels of CD95, but in
3 more days of culture up-regulated CD95 and became
susceptible to apoptosis (M.M.). This renders DC that
have reached complete maturation still sensitive to
suppressive stimuli of anergic/suppressor cells that can
regulate their functions at different moments of their
life-span.
Another very relevant ﬁnding is that anergic cells can
also determine death of responder T cells, but these latter
are eliminated only if responder and anergic T cells
recognize antigen on the same APC (Fig. 3b). This ensures
suppression to work as an antigen speciﬁc phenomenon.
Nevertheless, it remains to be clariﬁed if all responder
cells die and, if not, what the fate is of these surviving
cells. In other words, if “suppressed” cells (included
T cells suppressed in the presence of immature DC) are, in
turn, rendered tolerant or deleted by other means. Finally,
the low amount of CD40L on anergic cells fails to induce
up-regulation of an anti-apoptotic molecule such as Bcl-2
that may inhibit also spontaneous apoptotic of DC, a
phenomenon that we observed following 24–48h of co-
culture (not shown in this paper). Regarding this latter
point, although the mechanism of active death seems to be
the most relevant for T cell suppression (we could
signiﬁcantly abrogate suppression by using the
antagonistic anti-CD95 Ab in suppression experiments,
Fig. 3a) limitation of the half-life of DC available for
primary stimulation of other helper T cells or effector cells
(such as CD8 T cells) can also represent a crucial
parameter in the induction of cellular immune responses
(de Smedt et al., 1998; Miga et al., 2001).
MATERIAL AND METHODS
Reagents, T Cell Lines, Clones
Peptide HA307-19 was synthesized by F-MOC chemistry
(Frasca et al., 1997). Antibodies used were: OKT3 (anti-
human CD3, ATCC, Rockville, MD); antagonistic anti-
CD95 (M3, Immunex, Seattle, WA); anti-mouse IgG, for
cross-linking of CD40 mAb (Sigma Chemical Co.,
St. Louis, MO); L243 (IgG2a, anti-DR, ATCC); R-PE-
conjugated anti-CD154 (CD40L), (TRAP-1, BD PharMin-
gen, San Diego, CA). FITC-conjugated hamster anti-Bcl-2
(BD PharMingen). Anti CD86, Bu63, kindly provided by
PeterBeverly,London,UK.Anti-CD40L(blocking)24-31
(Alexis, Biochemicals, Vinci-Biochem, FI, Italy). T cell
clones F17, HA307-19-speciﬁc and DRB1*1101-
restricted, was derived from a DRB1*0101/DRB1*1101
individual. The homozigous lymphoblastoid cell line
(B-LCL) used as APC was Sweig (DRB1*1101,
DQA1*0501, DQB1*0301).
FIGURE 6 Anergic cells do not favor up-regulation of Bcl-2 in DC.
2 £ 10
4 “mature” DRB1*1101
þ DC, pulsed with HA307-19, were
cultured either alone (2) or with anergic (OKT3) or activated (PI) F17.
The cells were co-cultured at 378C for 48h and Bcl-2 expression on DC
was assessed by FACS after intracellular staining. Data shown, expressed
as mean of ﬂuorescence intensity (MFI), are from one of two separate
experiments.
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Characterization of Human DC
DC were prepared from PBMC of healthy donors.
Adherent cells were cultured in RPMI 2% HS plus
50ng/ml of GM-CSF and 100u/ml rIL-4 (Roche
Molecular Biochemicals, Mannheim, Germany). After 6






þ DC were deﬁned “immature
DC”. “Immature DC” reached spontaneous maturation
by up-regulating CD40, HLA-DR, CD86 and CD95
during a prolonged culture of at least 3 days (“mature
DC”). CD86, HLA-DR and Bcl-2 expression on DC co-
cultured T cells was assessed by staining with Bu63,
L243 and anti-Bcl-2 Abs, respectively. 10
4 “immature”
DC were cultured for 24 or 48h either alone or in the
presence of 10
5 T cells in ﬂat bottom 96-plates in RPMI
5% HS. Bcl-2 expression was tested on DC ﬁxed with
PBS 1 £ 2% paraformaldeide, washed in PBS 1 £ 0.5
BSA, 0.02% sodium azide and permeabilized in PBS
1 £ 0.5% BSA, 0.02% sodium azide, 0.5% saponine.
Isotype matched mAbs were always included and cells
analyzed by Beckton Dickinson FACScalibur ﬂow
cytometer (FACS).
Anergy Induction, T Cell Suppression Assay and
Cytotoxic Assay
T cell anergy was obtained as previously described by
incubating T cells overnight (o.n.) with immobilized mAb
anti-CD3 (OKT3). Lack of proliferation and IL-2
production, was tested in proliferation and CTLL-2
assay, respectively (Frasca et al., 1997). The cells that did
not proliferate and did not synthesize IL-2 were
considered “anergic”. For suppression experiments
T cells (5 £ 10
3) were cultured with 5 £ 10
3 irradiated
either “immature” or “mature” DC in ﬂat bottom
microtiter plates in a total volume of 200ml in RPMI
1640 (Gibco BRL, Paisley, Scotland), 10% HS,
plus/minus 1.5 £ 10
4 anergic T cells. In some experi-
ments responder T cells were also cultured with DC in the
presence of T cells activated with 0.05mM PMA (Sigma
Chemical Co.) þ0.5mM Ionomycin (Calbiochem,
La Jolla, CA) for 4h. After 48h wells were pulsed with
1mCi of
3H-TdR (Amersham International, Amersham,
UK) and harvested onto glass ﬁber ﬁlters 18h later.
Proliferation was measured as
3H-TdR incorporation by
liquid scintillation spectroscopy. The results are expressed
as mean counts of triplicate cultures. Standard errors were
routinely ,10%. Lytic activity of anergic T cells (effector
cells) on target DC or responder T cells was assessed by
standard
51Cr-release assay. Target cells 3 £ 10
3, labeled
with
51Cr for 1h, were cultured in a 96-well round-bottom
plate with 9 £ 10
3 effector cells (effector/target ratio 3:1).
Untreated responder T cells were also used as control
effectors and their killing activity was always
,10%. After 4h,
51Cr release in the supernatants was
determined on a ME Plus g-scintillation counter
(Micromedic Systems, Huntsville, TN). Speciﬁc lysis
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